GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (WBO:TLRY) » Definitions » Cyclically Adjusted Price-to-FCF

Tilray Brands (WBO:TLRY) Cyclically Adjusted Price-to-FCF : (As of Jun. 09, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Tilray Brands Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Tilray Brands Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Tilray Brands's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands Cyclically Adjusted Price-to-FCF Chart

Tilray Brands Annual Data
Trend Aug14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tilray Brands Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tilray Brands's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Tilray Brands's Cyclically Adjusted Price-to-FCF falls into.



Tilray Brands Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Tilray Brands's Cyclically Adjusted FCF per Share for the quarter that ended in Feb. 2024 is calculated as:

For example, Tilray Brands's adjusted Free Cash Flow per Share data for the three months ended in Feb. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=-0.031/125.4675*125.4675
=-0.031

Current CPI (Feb. 2024) = 125.4675.

Tilray Brands Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201405 -0.001 99.394 -0.001
201408 -0.018 99.315 -0.023
201411 -0.001 99.078 -0.001
201502 -0.035 99.078 -0.044
201505 -0.016 100.263 -0.020
201508 -0.031 100.579 -0.039
201511 -0.028 100.421 -0.035
201602 -0.014 100.421 -0.017
201605 -0.004 101.765 -0.005
201608 -0.059 101.686 -0.073
201611 -0.034 101.607 -0.042
201702 -0.147 102.476 -0.180
201705 -0.171 103.108 -0.208
201708 -0.151 103.108 -0.184
201711 -0.166 103.740 -0.201
201802 -0.428 104.688 -0.513
201805 -0.260 105.399 -0.310
201808 -0.249 106.031 -0.295
201811 -0.177 105.478 -0.211
201902 -0.225 106.268 -0.266
201905 -0.198 107.927 -0.230
201908 -0.201 108.085 -0.233
201911 -0.218 107.769 -0.254
202002 -0.298 108.559 -0.344
202005 -0.125 107.532 -0.146
202008 -0.245 108.243 -0.284
202011 -0.047 108.796 -0.054
202102 -0.011 109.745 -0.013
202105 0.008 111.404 0.009
202108 -0.207 112.668 -0.231
202111 -0.047 113.932 -0.052
202202 -0.092 115.986 -0.100
202205 -0.048 120.016 -0.050
202208 -0.085 120.569 -0.088
202211 0.040 121.675 0.041
202302 -0.030 122.070 -0.031
202305 0.042 124.045 0.042
202308 -0.027 125.389 -0.027
202311 -0.046 125.468 -0.046
202402 -0.031 125.468 -0.031

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tilray Brands  (WBO:TLRY) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Tilray Brands Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Tilray Brands's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Tilray Brands (WBO:TLRY) Business Description

Industry
Traded in Other Exchanges
Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.